Neural Stem Cells and Their Role in Regenerative Therapies for Spinal Cord Injury and Neurodegenerative Diseases

  • Authors

    • Sri Lekha Bandla Master’s in Biomedical Engineering, University of Bridgeport.
    https://doi.org/10.14419/3z52fd62

    Received date: May 4, 2025

    Accepted date: May 29, 2025

    Published date: July 18, 2025

  • Abstract

    This study presents a novel partial differential equation (PDE)-based model for neural stem cell (NSC) therapy in spinal cord injury (SCI) treatment. Existing models often fail to accurately represent NSC migration, differentiation, and interaction with biomaterials and immune responses. By integrating scaffold-mediated diffusion and immune response dynamics, the proposed model offers a more realistic framework for regenerative therapy optimization. The model improves upon previous approaches by providing precise control overgrowth factor distribution, ensuring sustained bioavailability for enhanced NSC survival and functional integration. Applications of this framework extend beyond SCI treatment, with potential implications for neurodegenerative diseases, brain injury repair, and personalized medicine. Future research will focus on experimental validation and machine learning-driven optimization to refine the predictive capabilities of the model.

  • References

    1. . S. Varadarajan et al., ”Central Nervous System Regeneration,” Cell, vol. 185, no. 1, pp. 77–94, 2024. [Online]. Available: https://doi.org/10.1016/j.cell.
    2. 10.029
    3. . Z. Gao et al., ”Restoring After Central Nervous System Injuries: Neural Mechanisms and Translational Applications of Motor Recovery,” Neuroscience
    4. Bulletin, vol. 38, no. 12, pp. 1569–1587, 2022. [Online]. Available: https://doi.org/10.1007/s12264-022-00959-x
    5. . F. Villanueva-Flores et al., ”Toward a New Generation of Bio-Scaffolds for Neural Tissue Engineering: Challenges and Perspectives,” Pharmaceutics,
    6. vol. 15, no. 6, p. 1750, 2023. [Online]. Available: https://doi.org/10.3390/pharmaceutics15061750
    7. . K. Sindhi et al., ”The role of biomaterials-based scaffolds in advancing skin tissue construct,” Journal of Tissue Viability, vol. 34, no. 2, p. 100858, 2025.
    8. [Online]. Available: https://doi.org/10.1016/j.jtv.2025.100858
    9. . A. Najihah et al., ”Current trend on preparation, characterization and biomedical applications of natural polysaccharide-based nanomaterial reinforcement
    10. hydrogels: A review,” International Journal of Biological Macromolecules, vol. 271, no. 2, p. 132411, 2024. [Online]. Available: https://doi.org/10.
    11. /j.ijbiomac.2024.132411
    12. . M. Saberian et al., ”How the combination of alginate and chitosan can fabricate a hydrogel with favorable properties for wound healing,” Heliyon, vol.
    13. , no. 11, p. e32040, 2024. [Online]. Available: https://doi.org/10.1016/j.heliyon.2024.e32040
    14. . J. George et al., ”Neural tissue engineering with structured hydrogels in CNS models and therapies,” Biotechnology Advances, vol. 42, p. 107370, 2020.
    15. [Online]. Available: https://doi.org/10.1016/j.biotechadv.2019.03.009
    16. . N. Almouemen et al., ”Tissue Engineering: Understanding the Role of Biomaterials and Biophysical Forces on Cell Functionality Through Computational
    17. and Structural Biotechnology Analytical Methods,” Computational and Structural Biotechnology Journal, vol. 17, pp. 591–598, 2019. [Online]. Available:
    18. https://doi.org/10.1016/j.csbj.2019.04.008
    19. . L. Papadimitriou et al., ”Biofabrication for neural tissue engineering applications,” Materials Today Bio, vol. 6, p. 100043, 2020. [Online]. Available:
    20. https://doi.org/10.1016/j.mtbio.2020.100043International
    21. X. Liu et al., ”Covalent crosslinking of graphene oxide and carbon nanotube into hydrogels enhances nerve cell responses,” Journal of Mater Chem B,
    22. vol. 4, no. 43, pp. 6930–694, 2022. [Online]. Available: https://doi.org/10.1039/c6tb01722c
    23. R. Bai et al., ”Graphene-based 3D scaffolds in tissue engineering: fabrication, applications, and future scope in liver tissue engineering,” International
    24. Journal of Nanomedicine, vol. 14, pp. 5753-5783, 2019. [Online]. Available: http://dx.doi.org/10.2147/IJN.S192779
    25. F. Sivandzade and L. Cucullo, ”Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview,” International Journal of Molecule
    26. Science, vol. 22, no. 4, p. 2153, 2021. [Online]. Available: https://doi.org/10.3390/ijms22042153
    27. L. Nie and D. Yao, ”Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke,” Cell Death Discovery,
    28. vol. 9, p. 215, 2023. [Online]. Available: https://doi.org/10.1038/s41420-023-01532-9
    29. K. Qian et al., ”Effects of neural stem cell transplantation on the motor function of rats with contusion spinal cord injuries: a meta-analysis,” Neural
    30. Regeneration Research, vol. 15, no. 4, pp. 748–758, 2019. [Online]. Available: https://doi.org/10.4103/1673-5374.266915
    31. M. Chehelgerdi et al., ”Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy,” Molecular Cancer, vol. 22,
    32. p. 189, 2023. [Online]. Available: https://doi.org/10.1186/s12943-023-01873-0
    33. T. Chen et al., ”Neural stem cells over-expressing brain-derived neurotrophic factor promote neuronal survival and cytoskeletal protein expression in
    34. traumatic brain injury sites,” Neural Regeneration Research, vol. 12, no. 3, pp. 433–439, 2017. [Online]. Available: https://doi.org/10.4103/1673-5374.
    35. W. Guo et al., ”The roles and applications of neural stem cells in spinal cord injury repair,” Frontiers in Bioengineering and Biotechnology, vol. 10, p.
    36. , 2022. [Online]. Available: https://doi.org/10.3389/fbioe.2022.966866
    37. C. Li et al., ”The roles of neural stem cells in myelin regeneration and repair therapy after spinal cord injury,” Stem Cell Research & Therapy, vol. 15,
    38. no. 1, 2024. [Online]. Available: http://dx.doi.org/10.1186/s13287-024-03825-x
    39. X. Tang, P. Deng et al., ”Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases,” Stem
    40. Cell Res Ther, vol. 15, p. 482, 2024. [Online]. Available: https://doi.org/10.1186/s13287-024-04089-1
    41. D. Dogbey et al., ”Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy,”
    42. Drug Deliv Transl Research, vol. 13, no. 11, pp. 2719–2738, 2023. [Online]. Available: https://doi.org/10.1007/s13346-023-01362-3
    43. E. Hudry and L. Vandenberghe, ”Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality,” Neuron, vol. 101, no. 5, pp. 839-862,
    44. [Online]. Available: https://doi.org/10.1016/j.neuron.2019.02.017
    45. Y. Ohtake et al., ”Promoting Axon Regeneration in Adult CNS by Targeting Liver Kinase B1,” Molecular Therapy, vol. 27, no. 1, pp. 102–117, 2018.
    46. [Online]. Available: https://doi.org/10.1016/j.ymthe.2018.10.019
    47. L. Quah, ”The CRISPR-Cas9 Genome Editing System,” AdvancedHealth, 2021. [Online]. Available: https://blog.advanxhealth.com/
    48. the-crispr-cas9-genome-editing-system/
    49. L. Quah, ”The CRISPR-Cas9 Genome Editing System,” AdvancedHealth, 2021. [Online]. Available: https://blog.advanxhealth.com/
    50. the-crispr-cas9-genome-editing-system/
    51. V. De Leo et al., ”Liposomes containing nanoparticles: preparation and applications,” Colloids and Surfaces B: Biointerfaces, vol. 218, p. 112737, 2022.
    52. [Online]. Available: https://doi.org/10.1016/j.colsurfb.2022.112737
    53. C. Egejuru et al., ”Nanomedicine: Application of Nanotechnology,” European Journal of Biomedical and Pharmaceutical Sciences, vol. 4, no. 12, pp. 136-
    54. , 2017. [Online]. Available: https://www.researchgate.net/publication/321963895 NANOMEDICINE APPLICATION OF NANOTECHNOLOGY
    55. Y. Shen et al., ”Advancements in Antioxidant-Based Therapeutics for Spinal Cord Injury: A Critical Review of Strategies and Combination Approaches,”
    56. Antioxidants (Basel), vol. 14, no. 1, p. 17, 2024. [Online]. Available: https://doi.org/10.3390/antiox14010017
    57. X. Lin et al., ”Hydrogels and hydrogel-based drug delivery systems for promoting refractory wound healing: Applications and prospects,” International
    58. Journal of Biological Macromolecules, vol. 285, p. 138098, 2025. [Online]. Available: https://doi.org/10.1016/j.ijbiomac.2024.138098
    59. Y. Zhang and B. Wu, ”Current Advances in Stimuli-Responsive Hydrogels as Smart Drug Delivery Carriers,” Gels, vol. 9, no. 10, p. 838, 2023. [Online].
    60. Available: https://doi.org/10.3390/gels9100838
    61. Y. Zhao et al., ”Using NGF heparin-poloxamer thermosensitive hydrogels to enhance the nerve regeneration for spinal cord injury,” Acta Biomater, vol.
    62. , pp. 71-80, 2020. [Online]. Available: https://doi.org/10.1016/j.actbio.2015.10.014
    63. [32] F. H. Gage, ”Mammalian Neural Stem Cells,” Science, vol. 280, no. 5364, pp. 91-96, 1998. [Online]. Available: 10.1126/science.280.5364.91
    64. G. Kumagai et al., ”Neural Stem Cells Derived from the Spinal Cord of Embryonic Mice for Transplantation in Spinal Cord Injury Models,” Experimental
    65. Neurology, vol. 162, pp. 104-110, 2000. [Online]. Available: 10.1006/exnr.2000.7461
    66. V. Sahni et al., ”Biomaterials and Gene Therapy Approaches for Neural Stem Cell-Based Spinal Cord Injury Therapies,” Biomaterials, vol. 27, pp.
    67. -2456, 2006. [Online]. Available: 10.1016/j.biomaterials.2005.10.027
    68. H. Peng et al., ”Research progress of hydrogels as delivery systems and scaffolds in the treatment of secondary spinal cord injury,” Frontiers Bioengineering Biotechnology, vol. 11, 2023. [Online]. Available: https://doi.org/10.3389/fbioe.2023.1111882

  • Downloads

  • How to Cite

    Sri Lekha Bandla. (2025). Neural Stem Cells and Their Role in Regenerative Therapies for Spinal Cord Injury and Neurodegenerative Diseases. International Journal of Applied Mathematical Research, 14(2), 10-20. https://doi.org/10.14419/3z52fd62